FORTIDE

This brand name is authorized in Nigeria.

Active ingredients

The drug FORTIDE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII Q3OKS62Q6X - BUDESONIDE
 

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.

 
Read more about Budesonide
2
UNII W34SHF8J2K - FORMOTEROL FUMARATE
 

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.

 
Read more about Eformoterol

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-9410 Spray, Metered-Dose FORTIDE INHALER 200MCG + 6MCG SPRAY_MET 200mcg+6mcg 1 X 120 127 RNW-PP-339245 FORTIDE INHALER 200MCG + 6MCG BUDESONIDE 200MCG + FORMOTEROL FUMARATE DIHYDRATE 6MCG BUDESONIDE BP… 200MCG FORMOTEROL FUMARATE DIHYDRATE PH. EUR. … 6MCG ALSO CONTAINS: CFC-FREE PROPELLANT, HFA 134A B4-9410 Drugs Imported Products 1120 POM 1 7/11/2023 GETZ PHARMA NIGERIA LIMITED, PLOT 2, IJAODOLA CLOSE, OFF ADEYEMO ALAKIJA STREET, IKEJA GRA, LAGOS. 8165370750 nneka.obegolu@getzpharma.com GETZ PHARMA (PRIVATE) LIMITED, 29 – 30/27, KORANGI INDUSTRIAL AREA,KARACHI-74900 PAKISTAN , Pakistan 21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03AK07 Formoterol and budesonide R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-9410

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.